# Study of Amantadine for Risperidone Consta or Paliperidone Treated Patients to Decrease Prolactin Elevation

> **NCT00975611** · PHASE4 · TERMINATED · sponsor: **David C. Henderson, MD** · enrollment: 6 (actual)

## Conditions studied

- Schizophrenia
- Schizoaffective Disorder

## Interventions

- **DRUG:** Amantadine Hydrochloride, USP
- **DRUG:** Amantadine Hydrochloride, USP
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00975611
- **Lead sponsor:** David C. Henderson, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-10
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** The sponsor withdrew support due to slow accrual of eligible subjects.
- **Last updated:** 2013-06-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00975611

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00975611, "Study of Amantadine for Risperidone Consta or Paliperidone Treated Patients to Decrease Prolactin Elevation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00975611. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*